NO20073097L - Anvendelse av tyrosin kinase inhibitorer for behandling av kronisk rinosinusit - Google Patents

Anvendelse av tyrosin kinase inhibitorer for behandling av kronisk rinosinusit

Info

Publication number
NO20073097L
NO20073097L NO20073097A NO20073097A NO20073097L NO 20073097 L NO20073097 L NO 20073097L NO 20073097 A NO20073097 A NO 20073097A NO 20073097 A NO20073097 A NO 20073097A NO 20073097 L NO20073097 L NO 20073097L
Authority
NO
Norway
Prior art keywords
treatment
kinase inhibitors
chronic
rhinosinusite
tyrosine kinase
Prior art date
Application number
NO20073097A
Other languages
English (en)
Norwegian (no)
Inventor
Gerald Pohl
Bernd Disse
Birgit Jung
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36228798&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20073097(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE102005005505A external-priority patent/DE102005005505A1/de
Priority claimed from DE102005036216A external-priority patent/DE102005036216A1/de
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of NO20073097L publication Critical patent/NO20073097L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
NO20073097A 2005-02-04 2007-06-18 Anvendelse av tyrosin kinase inhibitorer for behandling av kronisk rinosinusit NO20073097L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102005005505A DE102005005505A1 (de) 2005-02-04 2005-02-04 Verwendung von Tyrosinkinase-Inhibitoren zur Behandlung der chronischen Rhinosinusitis
DE102005036216A DE102005036216A1 (de) 2005-08-02 2005-08-02 Verwendung von Tyrosinkinase-Inhibitoren zur Behandlung der chronischen Rhinosinusitis
PCT/EP2006/050215 WO2006082129A1 (de) 2005-02-04 2006-01-16 Verwendung von tyrosinkinase-inhibitoren zur behandlung der chronischen rhinosinusitis

Publications (1)

Publication Number Publication Date
NO20073097L true NO20073097L (no) 2007-07-12

Family

ID=36228798

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20073097A NO20073097L (no) 2005-02-04 2007-06-18 Anvendelse av tyrosin kinase inhibitorer for behandling av kronisk rinosinusit

Country Status (14)

Country Link
US (1) US20060178364A1 (ru)
EP (1) EP1845992A1 (ru)
JP (1) JP2009523700A (ru)
KR (1) KR20070108889A (ru)
AR (1) AR055029A1 (ru)
AU (1) AU2006210175A1 (ru)
BR (1) BRPI0607358A2 (ru)
CA (1) CA2601740A1 (ru)
EA (1) EA200701619A1 (ru)
IL (1) IL184997A0 (ru)
MX (1) MX2007009265A (ru)
NO (1) NO20073097L (ru)
TW (1) TW200638937A (ru)
WO (1) WO2006082129A1 (ru)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009092052A2 (en) * 2008-01-18 2009-07-23 Massachusetts Eye And Ear Infirmary Methods and compositions for treating polyps
WO2010026029A1 (en) * 2008-09-03 2010-03-11 Boehringer Ingelheim International Gmbh Use of quinazoline derivatives for the treatment of viral diseases
WO2010054285A2 (en) 2008-11-10 2010-05-14 National Health Research Institutes Fused bicyclic and tricyclic pyrimidine compounds as tyrosine kinase inhibitors
CN104844580B (zh) * 2015-04-17 2017-10-20 中国药科大学 嘧啶类化合物、其制备方法及医药用途
US20170007704A1 (en) * 2015-07-09 2017-01-12 David Ram Carrier and pharmaceutical compositions for intrasinal delivery and uses thereof
PE20191303A1 (es) 2016-11-17 2019-09-23 Univ Texas Compuestos con actividad antitumoral contra celulas cancerosas que tienen mutaciones en el exon 20 de egfr o her2
RU2646806C1 (ru) * 2017-05-05 2018-03-07 Дмитрий Александрович Щербаков Способ лечения хронического полипозного риносинусита
KR20220057993A (ko) 2020-10-30 2022-05-09 오창민 코막힘, 콧물 등 알레르기 비염을 포함한 부비동 질환의 증상 개선을 위한 식품 조성물

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10042062A1 (de) * 2000-08-26 2002-03-07 Boehringer Ingelheim Pharma Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Hertellung
DE10204462A1 (de) * 2002-02-05 2003-08-07 Boehringer Ingelheim Pharma Verwendung von Tyrosinkinase-Inhibitoren zur Behandlung inflammatorischer Prozesse
IL164167A0 (en) * 2002-03-30 2005-12-18 Boehringer Ingelheim Pharma 4-(N-phenylamino)-quinazolines/ quinolines as tyrosine kinase inhibitors
DE10334226A1 (de) * 2003-07-28 2005-02-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verwendung von Tyrosinkinase-Inhibitoren zur Behandlung inflammatorischer Prozesse
DE10350717A1 (de) * 2003-10-30 2005-06-02 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verwendung von Tyrosinkinase-Inhibitoren zur Behandlung inflammatorischer Prozesse

Also Published As

Publication number Publication date
EP1845992A1 (de) 2007-10-24
KR20070108889A (ko) 2007-11-13
AR055029A1 (es) 2007-08-01
MX2007009265A (es) 2007-09-07
JP2009523700A (ja) 2009-06-25
US20060178364A1 (en) 2006-08-10
BRPI0607358A2 (pt) 2009-09-01
EA200701619A1 (ru) 2008-02-28
CA2601740A1 (en) 2006-08-10
AU2006210175A1 (en) 2006-08-10
WO2006082129A1 (de) 2006-08-10
IL184997A0 (en) 2007-12-03
TW200638937A (en) 2006-11-16

Similar Documents

Publication Publication Date Title
NO20073097L (no) Anvendelse av tyrosin kinase inhibitorer for behandling av kronisk rinosinusit
EA200870410A1 (ru) Антагонисты киназы
DE602007013295D1 (de) Substituierte isochinoline und ihre verwendung als rho-kinase-inhibitoren
ATE395346T1 (de) Chinazolinderivate als tyrosinkinaseinhibitoren
ATE554087T1 (de) Neue kinaseinhibitoren
WO2008078100A3 (en) Tricyclic amine derivatives as protein tyrosine kinase inhibitors
EA200970738A1 (ru) Ингибиторы активности akt
GEP20094623B (en) Heteroaromatic quinoline compounds and their use as pde10 inhibitors
NO20082089L (no) Fosfatidylinositol 3-kinaseinhibitorer og deres anvendelse
TW200801008A (en) Protein kinase inhibitors
EA201270553A1 (ru) Ингибиторы тирозинкиназы брутона
BRPI0512547A (pt) pirimidinas
EA201000093A1 (ru) Производные пиридазинона
ATE526325T1 (de) Substituierte benzimidazole als kinaseinhibitoren
NO20083923L (no) Pyrazolkinoloner er potente parp-inhibitorer
EA200900798A1 (ru) Производные индол-4-илпиримидинил-2-иламина и их применение в качестве ингибиторов циклинзависимой киназы
EA200901601A1 (ru) Производные пиридазинона
MXPA06010904A (es) Inhibidores de pirazol cinasa triciclicos.
ATE553104T1 (de) Substituierte 1h-benzimidazol-4-carboxamide als potente parp-hemmer
EA201100334A1 (ru) Бициклические производные триазола для лечения опухолей
EA201170831A1 (ru) Аминопиразольное соединение
DE602007004333D1 (de) Inhibitoren von akt (proteinkinase b)
DK1866433T3 (da) Fremgangsmåde til identifikation af LRRK-2interagerende molekyler og til rensning af LRRK2
DE502005007105D1 (de) 4-amino-5-oxo-8-phenyl-5h-pyrido-ä2,3-dü-pyrimidin-derivate als inhibitoren der tyrosinkinasen und der raf-kinasen zur behandlung von tumoren
NL1030487A1 (nl) Nieuwe, op pyrazool gebaseerde HMG-Co-A-reductaseremmers.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application